infecti
pathway
nonenvelop
human
papillomaviru
type
includ
bind
cell
surfac
clathrinmedi
endocytosi
penetr
endosom
infect
shown
decreas
presenc
lysosomotroph
neutral
agent
ammonium
chlorid
nh
cl
nh
cl
neutral
acid
endolysosom
compart
thu
suggest
ph
respons
pv
capsid
conform
chang
lead
endosom
escap
result
howev
data
suggest
nh
cl
block
infect
prevent
movement
pv
viral
particl
earli
endosom
caveosom
shown
jc
viru
confirm
hpv
infect
requir
traffick
reportervirion
caveosom
case
manuscript
propos
observ
decreas
infect
pv
presenc
nh
cl
due
loss
movement
reportervirion
caveosom
also
demonstr
cystein
proteas
involv
infecti
process
cathepsin
b
treatment
viral
particl
shown
overcom
block
infect
observ
presenc
furin
inhibit
confirm
need
cathepsin
b
infect
use
cathepsin
b
null
mous
embryon
fibroblast
present
data
suggest
infect
part
mediat
cystein
proteas
nh
cl
block
intracellular
traffick
infecti
viral
particl
knowledg
first
demonstr
cystein
proteas
influenc
infect
nonenvelop
viru
human
papillomavirus
hpv
nonenvelop
dna
virus
infect
skin
mucou
membran
hpv
known
caus
cutan
cervic
respiratori
wart
lesion
capsid
hpv
made
two
viral
encod
structur
protein
major
capsid
protein
primarili
involv
attach
viru
plasma
membran
minor
capsid
protein
function
viral
genom
traffick
encapsid
infecti
process
begin
via
virion
attach
cell
surfac
break
skin
although
virioncel
bind
process
still
unclear
thought
occur
initi
bind
protein
virion
capsid
heparan
sulfat
cell
surfac
proteoglycan
follow
bind
secondari
receptor
put
integrin
complex
shown
abl
mediat
cell
bind
studi
show
antibodi
could
block
virion
bind
epitheli
cell
hacat
keratinocyt
howev
integrin
may
necessari
requir
infect
sinc
studi
also
indic
pv
infect
cell
bosv
keratinocyt
lack
complex
attach
cell
surfac
virion
intern
via
mechan
begin
clathrin
mediat
endocytosi
nterminu
cleavag
furin
calcium
depend
serin
endoproteas
found
plasma
membran
golgi
endosom
suggest
requir
infect
data
suggest
traffick
endosom
reportervirion
may
follow
either
infecti
rout
noninfecti
rout
infecti
rout
reportervirion
move
intracellular
sort
pathway
pathway
shown
necessari
infect
infect
block
cell
protein
level
reduc
use
sirna
enter
caveosom
virion
shown
traffic
event
region
coloc
endoplasm
reticulum
er
tsnare
syntaxin
er
chaperon
calnexin
noninfecti
pathway
result
traffick
endosom
lysosom
reportervirion
may
process
degrad
cell
latter
pathway
shown
use
noninfecti
mutant
viru
neutral
antibodi
shown
ammonium
chlorid
nh
cl
block
infect
bovin
papillomaviru
type
pv
similar
kinet
nh
cl
neutral
acid
endolysosom
compart
suggest
ph
respons
pv
capsid
conform
chang
lead
viral
genom
releas
howev
data
present
manuscript
suggest
ammonium
chlorid
block
infect
prevent
movement
viral
particl
earli
endosom
caveosom
also
shown
jc
viru
manuscript
show
cystein
proteas
ph
may
respons
chang
lead
infect
cystein
proteas
function
intracellular
extracellular
molecul
cystein
proteas
cathepsin
b
associ
caveola
caveola
defin
small
invagin
plasma
membran
associ
lipid
raft
contain
similar
caveola
endolysosom
compart
within
cell
contain
cathepsin
b
addit
cathepsin
l
cathepsin
zymogen
proform
cleav
activ
form
exact
mechan
activ
well
understood
howev
activ
procathepsin
b
may
occur
protein
found
caveola
activ
procathepsin
l
may
occur
heparan
sulfat
possibl
receptor
pv
addit
caveola
endosom
cathepsin
found
associ
lipid
raft
suggest
cathepsin
may
need
upon
intern
break
apart
matric
viral
surfac
cathepsin
b
l
implic
mechan
bind
entri
disassembl
sever
envelop
virus
case
bind
treat
ebolaviru
reportervirion
cathepsin
l
enhanc
infect
cleav
remov
highli
glycosyl
mucin
domain
ebolaviru
glycoprotein
result
increas
bind
suggest
cathepsin
inde
present
cell
membran
fusion
envelop
virus
nipah
hendra
sar
coronaviru
murin
coronaviru
mous
hepat
viru
shown
depend
cathepsin
b
l
nipah
viru
cathepsin
b
l
shown
cleav
membran
fusion
protein
requir
viruscel
cellcel
membran
fusion
cleavag
viral
membran
fusion
protein
correct
size
necessari
matur
fusogen
form
cathepsin
b
shown
cleav
fusion
protein
cellfre
system
two
fragment
smaller
fragment
migrat
slower
fragment
produc
cleavag
occur
infect
suggest
fusion
protein
cleav
correct
size
cathepsin
l
abl
cleav
fusion
protein
fragment
correct
size
cellfre
system
suggest
although
cathepsin
b
l
catalyt
similar
may
distinct
targetsequ
specif
similar
nipah
viru
cathepsin
l
involv
cleav
hendra
viru
fusion
protein
activ
heterodim
sar
coronaviru
infect
cathepsin
l
need
cleav
spike
protein
one
four
major
structur
protein
two
subunit
one
high
bind
affin
receptor
mediat
fusion
viral
cellular
membran
requir
cathepsin
fusion
also
shown
murin
coronaviru
mous
hepat
viru
mhv
proteolysi
cathepsin
b
l
necessari
cleavag
spike
protein
addit
proteolysi
cathepsin
shown
import
disassembl
reoviru
use
mous
embryon
fibroblast
deriv
cathepsin
b
l
defici
wild
type
mice
studi
show
reoviru
disassembl
prohibit
absenc
cathepsin
b
l
manuscript
show
role
cathepsin
b
may
import
infect
knowledg
first
descript
role
cystein
proteas
nonenvelop
virion
test
experi
repeat
hacat
cell
show
presenc
either
nh
cl
cystein
proteas
inhibitor
decreas
infect
observ
compar
cell
infect
absenc
inhibitor
see
addit
file
data
suggest
role
cystein
proteas
infect
presenc
nh
cl
infect
level
shown
decreas
determin
nh
cl
abl
block
movement
reportervirion
earli
endosom
caveosom
infect
cell
presenc
absenc
mm
nh
cl
infect
gfpreport
reportervirion
assess
confoc
microscopi
stereolog
count
data
collect
minut
post
bind
earli
endosom
stain
goat
fig
red
hour
post
bind
stain
goat
anticaveolin
fig
red
particl
stain
use
monoclon
antibodi
fig
green
absenc
fig
presenc
nh
cl
fig
overlap
observ
fig
green
infect
reduc
presenc
cystein
proteas
inhibitor
figur
infect
reduc
presenc
cystein
proteas
inhibitor
infect
cell
alon
hpv
dsred
reportervirion
mock
control
infect
presenc
mm
lysosom
neutral
agent
nh
cl
nonperm
cystein
proteas
inhibitor
permeabl
cystein
proteas
inhibitor
permeabl
intracellular
cathepsin
b
inhibitor
cathepsin
l
inhibitor
infect
analyz
compar
hour
post
bind
fac
dsred
express
inhibitor
present
durat
infect
cell
alon
analyz
background
fluoresc
statist
analyz
tail
ttest
found
signific
p
ammonium
chlorid
block
traffick
caveosom
figur
ammonium
chlorid
block
traffick
caveosom
infect
cell
alon
absenc
c
presenc
b
mm
lysosom
neutral
agent
nh
cl
cell
harvest
minut
post
bind
earli
endosom
stain
goat
b
hour
post
bind
caveosom
stain
goat
anticaveolin
c
particl
stain
use
monoclon
antibodi
ad
imag
shown
zstack
obtain
confoc
microscopi
number
caveosom
e
reportervirion
e
coloc
caveosom
f
absenc
presenc
nh
cl
count
use
stereolog
softwar
earli
endosom
fig
red
indic
yellow
color
fig
yellow
observ
decreas
coloc
fig
green
stain
fig
red
presenc
nh
cl
compar
absenc
nh
cl
compar
fig
fig
yellow
comparison
percent
reportervirion
overlap
absenc
presenc
nh
cl
stereolog
show
statist
signific
chang
percent
reportervirion
coloc
caveosom
decreas
presenc
nh
cl
fig
caveosom
overlap
nh
cl
caveosom
overlap
nh
cl
decreas
coloc
statist
signific
p
tail
test
observ
drop
overal
number
caveosom
chang
number
intern
viral
particl
fig
decreas
infect
due
effect
nh
cl
reportervirion
see
addit
file
data
suggest
nh
cl
influenc
format
caveosom
movement
reportervirion
caveosom
similar
jc
viru
cystein
proteas
inhibitor
reduc
infect
want
determin
treat
purifi
reportervirion
cystein
proteas
influenc
infect
reportervirion
treat
cathepsin
b
cathepsin
l
proteas
variou
amount
time
ad
cell
infect
analyz
flow
cytometri
hour
dsred
express
treatment
cathepsin
b
proteas
minut
increas
infect
compar
untreat
reportervirion
fig
min
bar
vs
infectedw
nontreat
bar
observ
increas
peak
hour
fold
compar
nontreat
infect
fig
hr
bar
vs
infectedw
nontreat
bar
increas
infect
consid
statist
physiolog
signific
sinc
amount
infect
time
greater
control
lesser
increas
infect
observ
minim
hr
fig
hr
bar
cathepsin
l
proteas
treatment
enhanc
infect
level
untreat
reportervirion
fig
red
bar
data
suggest
treat
reportervirion
cathepsin
b
proteas
enhanc
infect
wherea
treatment
cathepsin
l
affect
experi
repeat
differ
report
virion
prepar
similar
result
reportervirion
known
requir
matur
step
incub
alreadi
matur
reportervirion
throughout
time
cours
ensur
increas
infect
observ
due
reportervirion
partial
matur
matur
thu
effici
infect
see
addit
file
result
indic
addit
incub
process
significantli
chang
infect
level
suggest
reportervirion
matur
ie
virion
matur
occur
addit
incub
p
test
experi
cell
order
determin
increas
infect
observ
proteas
treatment
reportervirion
due
chang
total
viru
bind
tritium
radiolabel
h
bind
studi
perform
h
reportervirion
incub
cathepsin
b
cathepsin
l
proteas
variou
amount
time
ad
cell
allow
bind
hour
thoroughli
wash
harvest
fix
analysi
scintil
counter
treatment
reportervirion
cathepsin
b
proteas
hour
increas
bind
fold
compar
nonproteas
treat
reportervirion
fig
hr
bar
p
test
cathepsin
l
proteas
treatment
hour
also
increas
bind
fold
p
test
fig
maxim
bind
observ
hour
treatment
either
proteas
result
increas
infect
cathepsin
b
treat
report
virion
increas
infect
cathepsin
l
treat
reportervirion
sinc
bind
increas
third
differ
consid
physiolog
signific
addit
statist
signific
bind
observ
decreas
cathepsin
b
l
treatment
hour
data
suggest
proteas
treatment
hour
increas
bind
longer
time
incub
result
loss
total
bind
increas
infect
proteas
treatment
reportervirion
may
direct
result
increas
bind
infect
shown
depend
furin
cleavag
event
proteolyt
event
thought
occur
initi
conform
chang
viral
capsid
determin
cystein
proteas
play
role
mediat
furin
proteas
cleavag
infect
cell
incub
furin
inhibitor
use
cystein
proteas
treat
reportervirion
cell
incub
furin
inhibitor
overnight
infect
reportervirion
treat
variou
amount
time
cathepsin
b
cathepsin
l
proteas
figur
cathepsin
b
l
treatment
increas
bind
report
viru
bind
compar
cell
incub
h
label
reportervirion
treat
variou
amount
time
pm
cathepsin
b
proteas
b
pm
cathepsin
l
proteas
amount
bind
quantifi
scintil
counter
presenc
h
statist
analyz
tail
ttest
found
signific
p
p
b
infect
analyz
flow
cytometri
hour
dsred
fluoresc
previous
describ
furin
inhibit
decreas
infect
compar
cell
infect
absenc
furin
inhibitor
fig
infect
infect
furin
inhibitor
bar
surpris
cathepsin
b
treat
reportervirion
hour
signific
increas
infect
level
p
test
presenc
furin
inhibitor
compar
infect
untreat
reportervirion
presenc
furin
inhibitor
compar
fig
hr
bar
infect
furin
inhibitor
bar
cathepsin
b
treat
reportervirion
hour
infecti
presenc
furin
inhibitor
infect
control
without
proteas
treatment
furin
inhibit
compar
fig
infect
hr
bar
reportervirion
treat
cathepsin
l
proteas
unabl
overcom
furin
inhibit
unabl
reach
level
compar
infect
control
without
furin
inhibit
fig
p
test
data
suggest
cathepsin
b
cathepsin
l
treatment
reportervirion
overcom
furin
inhibit
data
suggest
cathepsin
b
may
play
role
infect
pathway
cell
interest
determin
observ
cell
line
specif
perform
infect
experi
use
cathepsin
use
cathepsin
knockout
mef
abl
confirm
role
cathepsin
unlik
inhibitor
may
nonspecif
effect
host
cell
inhibit
target
lead
partial
effect
infect
knockout
mef
ensur
cathepsin
b
l
complet
absent
mef
defici
either
cathepsin
b
cathepsin
l
wild
type
mef
ie
cathepsin
b
l
posit
infect
reportervirion
analyz
infect
level
hour
compar
infect
cathepsin
b
wild
type
mef
fig
cath
b
cathepsin
b
defici
mef
suscept
infect
yield
infect
fig
cath
b
cathepsin
l
wild
type
mef
fig
cath
l
show
increas
infect
level
compar
cathepsin
l
defici
mef
fig
cath
l
infect
level
cell
alon
show
background
level
autofluoresc
fig
cell
alon
bar
data
suggest
cathepsin
b
proteas
requir
infect
mef
cathepsin
proteas
shown
abl
modifi
bind
entri
mani
envelop
virus
thu
influenc
infect
effici
manuscript
broaden
involv
cathepsin
proteas
nonenvelop
viru
show
cathepsin
proteas
play
role
infect
human
embryon
cell
hek
mous
embryon
fibroblast
mef
data
previous
obtain
laboratori
demonstr
infect
follow
nonclass
traffick
rout
postclathrinmedi
endocytosi
data
demonstr
reportervirion
endocytos
use
clathrinco
pit
reportervirion
found
earli
endosom
posit
vesicl
sort
posit
organel
put
caveosom
coloc
endoplasm
reticulum
er
marker
caveosom
origin
identifi
necessari
compon
traffick
subsequ
work
demonstr
reportervirion
seem
traffic
caveosom
way
endoplasm
reticulum
order
reach
caveosom
would
crosstalk
endosom
caveosom
crosstalk
describ
jc
viru
hpv
commonli
use
techniqu
use
determin
role
ph
endolysosom
viral
traffick
involv
use
lysosom
ph
neutral
chemic
ammonium
chlorid
nh
cl
prelack
infect
absenc
cathepsin
b
figur
lack
infect
absenc
cathepsin
b
infect
level
cathepsin
b
cathepsin
l
defici
wild
type
mef
cell
analyz
compar
hour
post
bind
fac
analysi
gfp
express
cell
alon
analyz
background
fluoresc
statist
analyz
tail
ttest
found
signific
differ
p
vent
acidif
vesicl
unfortun
treatment
also
result
loss
fusion
intracellular
vesicl
fact
shown
nh
cl
prevent
movement
jc
viru
endosom
caveosom
observ
loss
viral
infect
use
nh
cl
pose
two
hypothes
pv
infect
prevent
fusion
vesicl
nh
cl
prevent
function
endolysosom
proteas
prevent
convers
proinact
form
activ
form
data
shown
figur
confirm
inde
loss
movement
hpv
reportervirion
endosom
caveosom
could
account
loss
infect
observ
use
nh
cl
shown
fig
regard
role
endolysosom
proteas
focus
cystein
proteas
cathepsin
b
l
two
highli
abund
proteas
endolysosom
compart
mention
cathepsin
b
l
previous
shown
involv
viral
infect
data
show
broad
cystein
proteas
inhibitor
specif
cathepsin
b
l
inhibitor
abl
decreas
infect
thu
suggest
cystein
proteas
part
mediat
infect
cell
furin
proteas
shown
necessari
viral
infect
allow
escap
viral
particl
endosom
richard
rm
lowi
dr
schiller
jt
day
pm
richard
colleagu
theoriz
furin
allow
escap
reportervirion
endosom
observ
loss
endosom
marker
stain
overlap
reportervirion
data
support
loss
overlap
reportervirion
show
reportervirion
move
vesicl
unclear
richard
colleagu
propos
viral
particl
escap
furin
cleavag
shown
occur
capsid
conform
chang
address
cathepsin
b
l
play
role
capsid
structur
chang
aid
furin
cleavag
event
surpris
pretreat
purifi
viral
particl
cathepsin
b
cathepsin
l
abl
overcom
block
infect
observ
presenc
furin
inhibitor
signific
find
need
work
possibl
util
cathepsin
b
backup
mechan
furin
order
establish
infect
recent
studi
address
role
endosom
proteas
disassembl
author
negat
role
cathepsin
b
l
infecti
process
differ
studi
may
due
variat
inhibitor
cell
line
quantiti
viral
particl
use
paper
richard
colleagu
cathepsin
b
inhibitor
use
membran
imperm
inhibitor
would
shown
effect
intracellular
process
use
permeabl
nonperm
inhibitor
cathepsin
l
inhibitor
use
describ
cathepsin
l
inhibitor
conclus
drawn
specif
inhibitor
addit
observ
describ
richard
colleagu
seen
hpv
posit
cervic
carcinoma
hela
cell
studi
perform
adenoviru
transform
human
embryon
kidney
cell
line
mef
deriv
cathepsin
bdefici
mice
cathepsin
ldefici
mice
hela
cell
recent
shown
infect
nonclathrin
mediat
endocytosi
event
find
may
also
explain
differ
studi
final
experi
perform
paper
richard
colleagu
use
minimum
ng
pv
experi
carri
use
less
ng
ng
vlp
million
particl
differ
may
also
contribut
differ
result
summari
data
manuscript
support
process
infect
subject
partial
proteolysi
cathepsin
plasma
membran
endolysosom
posit
vesicl
work
pursu
role
cystein
proteas
hacat
keratinocyt
specif
biolog
signific
cellular
site
cathepsin
proteolysi
ongo
cathepsin
b
proteas
calbiochem
cathepsin
l
proteas
r
system
minneapoli
mn
use
concentr
pm
lower
concentr
compar
ebert
et
al
inhibitor
ad
cell
allow
incub
cell
co
hour
prior
infect
hr
incub
period
cell
place
ice
hpv
reportervirion
contain
dsred
gfp
transgen
ad
cell
ice
hour
allow
bind
hour
inhibitor
unbound
viru
remov
wash
replac
warm
plu
inhibitor
mef
treat
inhibitor
place
ice
hour
presenc
reportervirion
allow
bind
unbound
reportervirion
remov
wash
replac
warm
cell
incub
co
hour
cell
harvest
use
trypsin
cell
spun
min
g
pellet
wash
pb
resuspend
ul
pb
cell
count
fluoresc
activ
cell
sorter
fac
number
dsred
gfp
posit
cell
use
determin
percent
infect
cell
fac
perform
rfum
flow
cytometri
core
experi
repeat
use
reportervirion
made
differ
prepar
cell
transfect
coverslip
wash
pb
fix
paraformaldehyd
min
paraformaldehyd
remov
via
wash
pb
cell
permeabil
block
buffer
fish
skin
gelatin
sigma
triton
pb
min
coverslip
wash
pb
incub
appropri
primari
antibodi
dilut
block
buffer
dilut
antibodi
fluoresc
label
alexaflour
donkey
antimous
goat
antirabbit
chicken
antigoat
molecular
probesinvitrogen
eugen
use
secondari
antibodi
dilut
block
buffer
minut
incub
coverslip
incub
minut
invitrogen
carlsbad
ca
dilut
nuclear
stain
coverslip
mount
glass
slide
use
prolong
antifad
mount
medium
invitrogen
fluoresc
confoc
microscopi
stereolog
quantif
percentag
coloc
observ
imag
ie
merg
color
perform
use
olympu
fluoview
microscop
analyz
fluoview
stereolog
softwar
olympu
melvil
ny
microscopi
core
rosalind
franklin
univers
medicin
scienc
rfum
north
chicago
il
imag
shown
z
stack
cytotox
studi
variou
inhibitor
carri
use
celltiterglo
luminesc
cell
viabil
assay
kit
promega
madison
wi
cell
incub
variou
concentr
inhibitor
hour
supernat
trypsin
cell
collect
harvest
cell
suspens
ad
well
plate
celltiterglo
substrat
buffer
combin
ad
well
contain
sampl
reagent
cell
mix
min
shaker
room
temperatur
plate
allow
rest
room
temperatur
minut
analyz
biotek
synergi
ht
plate
reader
use
softwar
biotek
winooski
vt
sampl
analyz
triplic
reportervirion
made
describ
brief
cell
cotransfect
bicistron
plasmid
dsred
gfp
cdna
contain
packag
plasmid
construct
cell
gift
dr
day
schiller
nation
cancer
institut
nation
institut
health
bethesda
md
cell
harvest
lyse
hour
reportervirion
allow
matur
night
allow
proper
conform
capsid
protein
high
salt
extract
reportervirion
purifi
optiprep
gradient
via
ultracentrifug
titer
reportervirion
determin
fac
percentag
dsred
gfp
posit
cell
hour
infect
tritium
label
reportervirion
made
addit
h
hour
post
transfect
tritium
label
reportervirion
contain
dsred
transgen
ad
cell
ice
hour
allow
bind
without
intern
unbound
reportervirion
remov
wash
pb
cell
harvest
pb
spot
whatmann
paper
allow
dri
sampl
fix
trichloroacet
acid
tca
minut
precipit
ethanol
minut
sampl
analyz
ls
multipurpos
scintil
counter
beckman
coulter
palatin
il
experi
repeat
use
reportervirion
made
differ
prepar
particip
design
studi
draft
manuscript
author
read
approv
final
manuscript
